Cargando…

Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma

Multiple target inhibition has gained considerable interest in combating drug resistance in glioblastoma, however, understanding the molecular mechanisms of crosstalk between signaling pathways and predicting responses of cancer cells to targeted interventions has remained challenging. Despite the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papa, Eleanna, Weller, Michael, Weiss, Tobias, Ventura, Elisa, Burghardt, Isabel, Szabó, Emese
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870582/ https://www.ncbi.nlm.nih.gov/pubmed/29238047 http://dx.doi.org/10.1038/s41419-017-0051-2

Ejemplares similares

Endoglin and TGF-β signaling in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021)

Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition
por: Silginer, Manuela, et al.
Publicado: (2023)

Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition
por: Krishnan, Shanmugarajan, et al.
Publicado: (2015)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
por: Cruickshanks, Nichola, et al.
Publicado: (2017)

A tumor-promoting role for soluble TβRIII in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021)

Translation of circHGF RNA encodes an HGF protein variant promoting glioblastoma growth through stimulation of c-MET
por: Saunders, Jacquelyn T., et al.
Publicado: (2023)

HGF/c-Met related activation of β-catenin in hepatoblastoma
por: Purcell, Rachel, et al.
Publicado: (2011)

TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms
por: Fang, Wei Bin, et al.
Publicado: (2015)

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma
por: Wirsching, Hans-Georg, et al.
Publicado: (2020)

HGF-MET as a breast cancer biomarker
por: Liu, Shuying
Publicado: (2015)

HGF/c-MET Signaling in Melanocytes and Melanoma
por: Czyz, Malgorzata
Publicado: (2018)

HGF–Met Pathway in Regeneration and Drug Discovery
por: Matsumoto, Kunio, et al.
Publicado: (2014)

HGF/Met Axis in Heart Function and Cardioprotection
por: Gallo, Simona, et al.
Publicado: (2014)

Physiological Signaling and Structure of the HGF Receptor MET
por: Baldanzi, Gianluca, et al.
Publicado: (2014)

HGF/MET Signaling in Malignant Brain Tumors
por: Mulcahy, Elizabeth Qian Xu, et al.
Publicado: (2020)

Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion
por: Cao, Hui-Hui, et al.
Publicado: (2015)

HGF-independent Potentiation of EGFR Action by c-Met
por: Dulak, Austin M., et al.
Publicado: (2011)

Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
por: Venepalli, Neeta K., et al.
Publicado: (2013)

The role of HGF/c-MET signaling pathway in lymphoma
por: Lam, Bao Quoc, et al.
Publicado: (2016)

HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
por: Papaccio, Federica, et al.
Publicado: (2018)

Cyclic Peptide-Based Biologics Regulating HGF-MET
por: Sato, Hiroki, et al.
Publicado: (2020)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

Targeting HGF/c-MET Axis in Pancreatic Cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2020)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)

HGF and MET: From Brain Development to Neurological Disorders
por: Desole, Claudia, et al.
Publicado: (2021)

Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling
por: Owusu, Benjamin Y., et al.
Publicado: (2016)

Expression of HGF and c-Met Proteins in Human Keratoconus Corneas
por: You, Jingjing, et al.
Publicado: (2015)

Activated HGF-c-Met Axis in Head and Neck Cancer
por: Arnold, Levi, et al.
Publicado: (2017)

HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
por: Spina, Anna, et al.
Publicado: (2015)

HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling
por: Xiang, Chuan, et al.
Publicado: (2017)

HGF/c-Met: A Key Promoter in Liver Regeneration
por: Zhao, Yang, et al.
Publicado: (2022)

Role of HGF/c-Met in Serum-Starved ARPE-19 Cells
por: Jun, Eun Jung, et al.
Publicado: (2007)

HGF and c-Met Interaction Promotes Migration in Human Chondrosarcoma Cells
por: Tsou, Hsi-Kai, et al.
Publicado: (2013)

Epigenetic Upregulation of HGF and c-Met Drives Metastasis in Hepatocellular Carcinoma
por: Ogunwobi, Olorunseun O., et al.
Publicado: (2013)

Differential expression of genes encoding proteins of the HGF/MET system in insulinomas
por: Murat, Cahuê De Bernardis, et al.
Publicado: (2015)

Corrigendum to “Expression of HGF and c-Met Proteins in Human Keratoconus Corneas”
por: You, Jingjing, et al.
Publicado: (2016)

Met and its ligand HGF are associated with clinical outcome in breast cancer
por: Veenstra, Cynthia, et al.
Publicado: (2016)

Quantitative imaging for development of companion diagnostics to drugs targeting HGF/MET
por: Huang, Fangjin, et al.
Publicado: (2016)

Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
por: Pothula, Srinivasa P., et al.
Publicado: (2017)

Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
por: Demkova, Lucia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gf24qlnindbmgpejm1ha3im205